arrow_back Trending Legislation
Share share

Reauthorizing Congenital Heart Disease Research and Care Program until 2029

This Act renews federal funding for the Congenital Heart Disease (CHD) research, surveillance, and awareness program until 2029. This means the government will continue collecting data and supporting research into the lifelong needs of CHD patients, including adults. For citizens, this translates into potentially better quality of care, increased knowledge about living with heart defects, and efforts to increase the number of specialists treating adult CHD patients.
Key points
Funding Extension: The Congenital Heart Disease (CHD) research and surveillance program is reauthorized for the years 2025 through 2029.
Improved Adult Care: Requires convening an expert workshop to identify research gaps and needs for adult CHD patients (mental health, quality of life, long-term outcomes).
Addressing Workforce Shortages: Mandates assessing the capacity of healthcare providers treating adult CHD patients and developing strategies to address any shortages, potentially through fellowship training programs.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Congenital Heart Futures Reauthorization Act of 2024
Print number: S 3757
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2024-02-07